TITLE:
      Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
SUMMARY:
      The purpose of this study is to determine the efficacy and safety of a
      buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for
      opiate-dependence treatment.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 21-50. Meet DSM-IV criteria for opiate dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
